These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24974976)

  • 1. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
    Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K
    Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
    Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S
    Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathies regardless of subtypes are associated with poor prognosis of diffuse large B-cell lymphoma: A STROBE-compliant article.
    Zhang Y; Wei Z; Li J; Gao R; Liu P
    Medicine (Baltimore); 2018 Jul; 97(30):e11719. PubMed ID: 30045337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the global burden of Epstein-Barr virus-related cancers.
    Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 18 children with aggressive mature B-cell lymphoma after liver transplantation].
    Zhao JC; Feng MX; Su M; Han YL; Xue F; Tang YJ; Zhang AA; Tang JY; Gao YJ
    Zhonghua Er Ke Za Zhi; 2024 Jun; 62(6):553-558. PubMed ID: 38763878
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.
    Chao C; Silverberg MJ; Martínez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J
    Clin Cancer Res; 2012 Sep; 18(17):4702-12. PubMed ID: 22711707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of diffuse large B cell lymphoma.
    Kwak JY
    Korean J Intern Med; 2012 Dec; 27(4):369-77. PubMed ID: 23269875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS.
    Li JW; Deng C; Zhou XY; Deng R
    Heliyon; 2024 Jan; 10(1):e23921. PubMed ID: 38234917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Epstein-Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma.
    Mangiaterra T; Alonso-Alonso R; Rabinovich A; De Dios Soler M; Galluzzo L; Soria M; Colli S; De Matteo E; Rodriguez Pinilla SM; Chabay P
    Cancer Immunol Immunother; 2024 Jan; 73(2):29. PubMed ID: 38280007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus positive diffuse large B-cell lymphoma transformed into angioimmunoblastic T-cell lymphoma after treatment.
    Wang C; Gong Y; Jiang Q; Liang X; Chen R
    Clin Case Rep; 2021 May; 9(5):e04083. PubMed ID: 34084501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
    Bourbon E; Maucort-Boulch D; Fontaine J; Mauduit C; Sesques P; Safar V; Ferrant E; Golfier C; Ghergus D; Karlin L; Lazareth A; Bouafia F; Pica GM; Orsini-Piocelle F; Rocher C; Gros FX; Parrens M; Dony A; Rossi C; Ghesquières H; Bachy E; Traverse-Glehen A; Sarkozy C
    Blood Adv; 2021 Aug; 5(16):3227-3239. PubMed ID: 34427583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
    Borchmann P; Heger JM; Mahlich J; Papadimitrious MS; Riou S; Werner B
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7091-7101. PubMed ID: 36871091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management.
    Malpica L; Marques-Piubelli ML; Beltran BE; Chavez JC; Miranda RN; Castillo JJ
    Am J Hematol; 2024 Jul; ():. PubMed ID: 38957951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the prevalence of Epstein-Barr virus in primary gastric lymphoma: a systematic review and meta-analysis.
    Hirabayashi M; Traverse-Glehen A; Combes JD; Clifford GM; de Martel C
    Infect Agent Cancer; 2023 Feb; 18(1):8. PubMed ID: 36765388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma.
    Davis CC; Cohen JB; Shah KS; Hutcherson DA; Surati MJ; Valla K; Panjic EH; Handler CE; Switchenko JM; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):270-7. PubMed ID: 25704479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
    Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM
    Br J Haematol; 2017 Jul; 178(1):72-80. PubMed ID: 28542862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.
    Abrahão R; Ribeiro RC; Lichtensztajn DY; Rosenberg AS; Keegan THM
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27559. PubMed ID: 30511461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytological Features of Fibrin-associated Diffuse Large B-cell Lymphoma Arising in Retroperitoneal Pseudocyst: The First Case Report.
    Na K; Kim SW; Kim HS
    In Vivo; 2024; 38(3):1477-1482. PubMed ID: 38688594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPSTEIN -BARR VIRUS ASSOCIATION WITH MALIGNANT LYMPHOMA SUBGROUPS IN ZARIA, NIGERIA.
    Iliyasu Y; Ayers LW; Liman AA; Waziri GD; Shehu SM
    Niger J Surg Sci; 2014; 23(1):6-8. PubMed ID: 25620871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center.
    Bakanay SM; Kaygusuz G; Topçuoğlu P; Sengül S; Tunçalı T; Keven K; Kuzu I; Uysal A; Arat M
    Turk J Haematol; 2014 Mar; 31(1):79-83. PubMed ID: 24764734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.